Zosano Pharma Corporation

NASDAQ: ZSAN · Real-Time Price · USD
0.56
0.00 (0.43%)
At close: Apr 24, 2025, 3:47 PM

Zosano Pharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
785K
Cost of Revenue
796K
Gross Profit
-11K
Operating Income
-29.74M
Interest Income
3K
Pretax Income
-29.93M
Net Income
-30.11M
Selling & General & Admin
10.55M
Research & Development
20.97M
Other Expenses
n/a
Operating Expenses
31.52M
Interest Expense
189K
Selling & Marketing Expenses
n/a
Cost & Expenses
32.32M
Income Tax Expense
189K
Shares Outstanding (Basic)
112.06M
Shares Outstanding (Diluted)
112.06M
EPS (Basic)
-0.27
EPS (Diluted)
-0.27
EBITDA
-27.98M
EBIT
-29.74M
Depreciation & Amortization
1.75M